• Affiliate Associate Professor, Global Health

Seattle, WA
United States

Phone Number: 
Select from the following:
  • PhD (Harvard University)
  • AM (Harvard University)
  • BS (Harvey Mudd College (California))
Country Affiliations 
Health Topics 
  • Bioengineering
  • Drug and Vaccine Development
  • Infectious Diseases (other than STDs)
  • Innate Immunity
  • Malaria
DGH Centers, Programs and Initiatives and Affiliated Organizations 

Kain HS, Glennon EKK, Vijayan K, Arang N, Douglass AN, Fortin CL, Zuck M, Lewis AJ, Whiteside SL, Dudgeon DR, Johnson JS, Aderem A, Stevens KR, Kaushansky A. Liver stage malaria infection is controlled by host regulators of lipid peroxidation. Cell Death Differ. 2019 May 7. Epub ahead of print. PMID: 31065106.

Glennon EK*, Austin LS*, Kain HS, Arang N, Douglass AN, Mast FD, Aitchison JD, Kappe SHI and Kaushansky A. Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection. Cell Reports. 2019 Mar 19;26 (12):3391:3399.e4. PMID: 30893610. PMCID: PMC6447308.

Arang N, Kain HS*, Glennon EK*, Bello T*, Dudgeon DR, Walter ENF, Gujral TS, Kaushansky A. Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles. *equal contribution. Nature Communications 2017 Nov 1;8(1):1232. PMID: 29089541. PMCID: PMC5663700.

Kaushansky A, Douglass AN, Arang N, Vigdorovich V, Dambrauskas N, Kain HS, Austin LS, Sather DN, Kappe SHI. Malaria parasites target the hepatocyte receptor EphA2 for successful host infection. Science 2015 Nov 27;350(6264):1089-92. PMID: 26612952. PMCID: PMC4783171.

Douglass AN, Kain HS, Abdullahi M, Arang N, Austin LS, Mikolajczak SA, Billman ZP, Hume JC, Murphy SC, Kappe SHI, Kaushansky A. Host-based prophylaxis successfully targets liver stage malaria parasites. Mol. Therapy. 2015 May;23(5):857-865. PMID: 25648263. PMCID: PMC4427874.